CGIDR Stories

How 3D Brain Vessels-On-Chip Can Contribute to Cerebral Malaria Research

Learn more about how a 3D brain microvessel model is helping researchers learn more about cerebral malaria. Read more.

Publication Q&A: Liver Stage Malaria Infection is Controlled by Host Regulators of Lipid Peroxidation

Dr. Alexis Kaushansky shares insights from a recent publication in Cell Death & Differentiation with contributing authors from Kaushansky and Aderem labs at the Center for Global Infectious Disease Research (CGIDR). Read more.

Publication Q&A with Maria Bernabeu

Meta-analysis of Plasmodium falciparum var Signatures Contributing to Severe Malaria in African Children and Indian Adults

Dr. Maria Bernabeu shares insights from a recent publication in mBio with contributing authors from the Smith and Aitchison labs. Read more.

ODELAY! Measuring Growth, Cell by Cell

Learn about a unique tool and experimental workflow developed by scientists at the Center for Global Infectious Disease Research to measure the many parameters of cell growth on single cells as they grow into colonies. Read more.

Opportunities for Host-Targeted Therapies for Malaria

Cell Press announces one of the best reviews published in 2018 is from Alexis Kaushansky and her colleagues which describes host factors and dependencies that contribute to malaria pathogenesis during various parasite life cycle stages and their potentials for host-targeted therapies. Read more.

Scientist Reflects on Lessons Learned From Nobel Prize Winner

Dr. Shuyi Ma shares her reaction to the news that her undergraduate mentor became the fifth woman in history to receive the Nobel Prize in Chemistry and shares how her mentor helped shaped her career. Read more.

CGIDR Researchers Awarded $17.2 Million Tuberculosis Grant From NIH

The Researchers from the Center for Global Infectious Disease Research (CGIDR) have been awarded a grant from the National Institute of Allergy and Infectious Diseases, one of the U.S. National Institutes of Health, to take a systems-level approach to the critical problem of tuberculosis (TB) infection, specifically focusing on the progression from infection to disease, and variability of treatment. Read more.